AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Ovarian Neoplasms

10
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00001272
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
Completed · Phase 1
NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Completed · Phase 3
NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Ovarian Neoplasms
🏥 Names
Disease Name
Ovarian Neoplasms
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Ovarian Neoplasms
topic type
disease
tcmsp disease id
598

🌿 Related Herbs

1 · contains this compound

🧬 Gene / Protein Targets

2 · genes implicated in this disease
Cytochrome P450 1A2
Glutathione S-transferase P

📋 Clinical Trials

10 · subject of clinical study
NCT00001272 A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Sti
→ Ovarian Neoplasms
NCT01015118 LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel an
→ Ovarian Neoplasms|Peritoneal Neoplasms
NCT00191646 An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That
→ Genital Neoplasms, Female|Fallopian Tube Neoplasms
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standar
→ Genital Diseases, Female|Ovarian Diseases|Ovarian
NCT01616303 A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemothera
→ Ovarian Neoplasms
NCT02429687 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
→ Ovarian Germ Cell Cancer|Ovarian Neoplasms|Ovarian
NCT02429700 TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
→ Ovarian Sex Cord Stromal Tumor|Ovarian Neoplasms|O
NCT03648489 Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube o
→ Ovarian Cancer|Ovarian Neoplasms|Ovarian Carcinosa
NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovari
→ Carcinoma, Ovarian Epithelial|Ovarian Neoplasms|Ov
NCT05185947 Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Perit
→ Gynecologic Cancer|Gynecologic Neoplasms|Peritonea
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables